Research

Complex Coronary / Valvular / Endovascular Interventions

Admin

18 Mar 2026 — 1 min read

This section outlines the extensive clinical expertise and innovative endovascular techniques developed for treating complex cardiovascular conditions, including high-risk coronary procedures and novel access closure solutions.

Complex high risk coronary interventional procedures (CHIP)

1,000+ cases encompassing the full spectrum of advanced coronary intervention:

Left main interventions
Chronic total occlusions (CTO)
Complex bifurcation stenosis
Bypass graft disease, with special interest in debulking atherectomy

Impella Pump - Percutaneous ventricular assist device (PVAD)

108 cases spanning both established and novel indications:

Acute coronary interventions for patients in cardiogenic shock
Novel indications for Impella use in cardiomyopathy and congestive heart failure
Impella deployment in peripheral arterial disease (PAD) patients through innovative access techniques

Novel Large-Bore Access Closure Solutions

Pioneering techniques for percutaneous closure of large-bore arterial access sites, published in peer-reviewed literature:

Ramesh K. Adiraju. Access Closure Innovations. Journal of Indian College of Cardiology. Available online July 1, 2017. ISSN 1561-8811. DOI:10.1016/j.jicc.2017.06.014

Nephro-Protection Protocol — IV Fenoldopam

103-case series documenting a novel protocol for renal protection and recovery of renal dysfunction during coronary and endovascular procedures using intravenous Fenoldopam.

Overview

The Dysautonomia Research Institute, founded by Dr. Ramesh Adiraju in 2005, is a clinical research and innovation center focused on advancing treatment protocols for dysautonomia and complex cardiovascular conditions. Dr. Ramesh Adiraju, MD, FACC Co-Founder & Chief Medical Officer, Autonomic Health Founder, Dysautonomia Research Institute Dr. Ramesh Adiraju is a

Faculty Positions and Clinical Assignments

Dr. Adiraju holds prestigious faculty positions and clinical assignments at international institutions, contributing to the global advancement of interventional cardiology and autonomic medicine. Key Appointments & Faculty Roles * Invited Faculty, Joint Interventional Meeting (JIM), 2013 Rome, Italy * Course Co-Director, Asia Pacific Vascular Interventional Course (APVIC), New Delhi, India-2014, 2015, 2016,

Novel Cardiomyopathy/Heart Failure Management

Heart failure with reduced ejection fraction (HFrEF) is a rapidly growing cardiovascular problem with ongoing research for optimal solutions. Congestive heart failure is the final common pathway for most cardiovascular illnesses. The number of adults in the U.S. living with heart failure rose by approximately 800,000 from 5.

Dysautonomia Regulation Approach for Disease Management

What happens when our autonomic nervous system gets out of balance? Our highly complex body is kept functioning efficiently under widely varying physical and emotional conditions by a central control system continuously running in the background. This is the autonomic nervous system and the Hypothalamus - central vagal axis or